Peptide Drugs advanced
PIONEER 9 Trial
Clinical trial evaluating iGlarLixi fixed-ratio glargine-lixisenatide versus glargine alone.
By Encyclopeptide Editorial | 1 min read
insulin glp1-combination clinical-trial
PIONEER 9 Trial
Overview
Clinical trial evaluating iGlarLixi fixed-ratio glargine-lixisenatide versus glargine alone.
Structure
| Property | Value |
|---|---|
| Name | PIONEER 9 Trial |
Mechanism of Action
Fixed-ratio combination showed superior HbA1c reduction with weight loss benefit.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | PIONEER 9 Trial |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about PIONEER 9 Trial with interactive quizzes on Wikipept.
Take a Quiz on Wikipept